KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Tax Provisions (2016 - 2025)

AbbVie (ABBV) has disclosed Tax Provisions for 14 consecutive years, with $853.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Tax Provisions rose 137.98% to $853.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.4 billion, a 514.74% increase, with the full-year FY2025 number at $2.4 billion, up 514.74% from a year prior.
  • Tax Provisions was $853.0 million for Q4 2025 at AbbVie, up from $526.0 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $853.0 million in Q4 2025 to a low of -$2.2 billion in Q4 2024.
  • A 5-year average of $312.2 million and a median of $442.0 million in 2022 define the central range for Tax Provisions.
  • Peak YoY movement for Tax Provisions: skyrocketed 756.52% in 2021, then crashed 4592.0% in 2024.
  • AbbVie's Tax Provisions stood at $226.0 million in 2021, then surged by 118.14% to $493.0 million in 2022, then crashed by 89.86% to $50.0 million in 2023, then plummeted by 4592.0% to -$2.2 billion in 2024, then surged by 137.98% to $853.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Tax Provisions are $853.0 million (Q4 2025), $526.0 million (Q3 2025), and $613.0 million (Q2 2025).